Freeline Therapeutics
Tihomir Dodev is a Senior Research Scientist at Freeline Therapeutics Limited since September 2016, with a strong background in B cell biology. Prior experience includes serving as a Senior Postdoctoral Research Associate at King's College London from March 2009 to August 2016, focusing on B cell antibody repertoire development in older populations and extensive hands-on experience in antibody library generation, high-throughput sequencing, and antibody characterization. Tihomir's academic credentials include a Ph.D. in Molecular Biology from King's College London and a BSc in Biotechnology from Università degli Studi di Perugia. Early career internships provided foundational expertise in mammalian expression vectors and protein purification techniques, contributing to a comprehensive understanding of molecular biology and antibody production processes.
This person is not in any offices
Freeline Therapeutics
Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.